News & Podcast
Stay up to date with the latest stories, deep-dives and interviews from the Munich startup ecosystem. From funding deals to founder portraits and tech trends.
Format:Category:
2 Results– filtered by:#Cellbyte
Interviews
Cellbyte: AI accelerates market access for pharma
Cellbyte wants to revolutionize the global market launch of medicines: with an AI-native platform, the Munich startup automates pricing and market access processes in the pharmaceutical industry. Over 100 data sources, deep industry knowledge, and regulatory expertise enable complex decisions in seconds.
12.01.26
4 Min.
Deals
Seed funding for Cellbyte
Cellbyte receives 2.4 million euros (2.75 million dollars) to expand its AI platform, which enables faster and informed decisions in the pharmaceutical industry for launching new drugs.
25.11.25
3 Min.